BHLHE40 and metastatic malignant neoplasm: We also observed step-wise increases in cytoplasmic and decreases in nuclear immunoreactivity of SHARP-2 between the normal breast, primary and metastatic cancer tissues; this may be explained by nucleocytoplasmic shuttling events.